TGFB1 and cancer: It is an accepted paradigm that long-term expression of TGFβ1 promotes a more malignant phenotype, and this is certainly born out by in vitro studies of TGFβ1-treated SCC cells and elevated expression of TGFβ1 in mouse and human cancers where pathway inactivation occurs.